Study Summary
The primary objective of this trial is to improve the overall survival rate of children and young adult with B-lineage acute lymphoblastic leukemia (B-ALL) in Singapore and Malaysia in the context of a multicenter cooperative trial using a risk-stratified therapy.
Want to learn more about this trial?
Request More InfoInterventions
PrednisoloneDRUG
Oral
DexamethasoneDRUG
Oral
VincristineDRUG
Intravenous
MethotrexateDRUG
Oral/ intrathecal/intravenous/subcutaneous
L-AsparaginaseDRUG
Intramuscular
Pegylated asparaginaseDRUG
Intravenous
ErwinaseDRUG
Optional for those allergic to E.coli/PEG L-asparaginase (intravenous)
DasatinibDRUG
Indicated only for ALL with BCR::ABL1 /BCR::ABL1-like/ tyrosine kinase fusion positive (oral)
ImatinibDRUG
Indicated only for ALL with BCR::ABL1 /BCR::ABL1-like/ tyrosine kinase fusion positive (oral)
CyclophosphamideDRUG
Intravenous
CytarabineDRUG
Subcutaneous/ Intravenous
MercaptopurineDRUG
Oral
ThioguanineDRUG
Oral
RituximabDRUG
Intravenous
DoxorubicinDRUG
Intravenous
FludarabineDRUG
Intravenous
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Subang Jaya Medical Centre | Kuala Lumpur | Malaysia | |
| University Malaya Medical Centre | Kuala Lumpur | Malaysia | |
| KK Women's and Children's Hospital | Singapore | Singapore |